Basics |
Invivyd, Inc.
|
IPO Date: |
August 6, 2022 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$238.69M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.08 | 5.12%
|
Avg Daily Range (30 D): |
$0.04 | 5.21%
|
Avg Daily Range (90 D): |
$0.04 | 4.99%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.81M |
Avg Daily Volume (30 D): |
7.77M |
Avg Daily Volume (90 D): |
3.51M |
Trade Size |
Avg Trade Size (Sh.): |
296 |
Avg Trade Size (Sh.) (30 D): |
389 |
Avg Trade Size (Sh.) (90 D): |
371 |
Institutional Trades |
Total Inst.Trades: |
38 |
Avg Inst. Trade: |
$2.65M |
Avg Inst. Trade (30 D): |
$1.86M |
Avg Inst. Trade (90 D): |
$1.86M |
Avg Inst. Trade Volume: |
1.18M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.28M |
Avg Closing Trade (30 D): |
$4.4M |
Avg Closing Trade (90 D): |
$4.4M |
Avg Closing Volume: |
2.64M |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.12
|
$-.14
|
$-.15
|
Diluted EPS
|
$-.12
|
$-.14
|
$-.15
|
Revenue
|
$ 11.79M
|
$ 11.3M
|
$ 13.82M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.66M
|
$ -16.29M
|
$ -18.44M
|
Operating Income / Loss
|
$ -15.06M
|
$ -16.92M
|
$ -19.23M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -13.18M
|
$ -21.26M
|
$ -37.53M
|
PE Ratio
|
|
|
|
|
|
|